Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized Double-blind Study to Compare the Safety and Performance of a Combination of A-PRP and XLHA Prepared With the RegenMatrix Medical Device, to Hylan G-F 20 XLHA and Placebo to Treat Moderate/Severe Knee Osteoarthritis

NCT05727371 is registered in ClinicalTrials.gov with RegenLab France SAS as lead sponsor.

NCT NCT05727371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05727371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized Double-blind Study to Compare the Safety and Performance of a Combination of A-PRP and XLHA Prepared With the RegenMatrix Medical Device, to Hylan G-F 20 XLHA and Placebo to Treat Moderate/Severe Knee Osteoarthritis
Lead sponsor
RegenLab France SAS
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 21, 2023
Completion date
August 30, 2026
Enrollment
280 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis